Pluripotent plasticity of stem cells and liver repopulation

Cell Biochemistry and Function

Volumn 28, Issue 3, 2010, Pages 178-189

  Gennero, Luisa ^a,b,c   Roos, Maria Augusta ^a   Sperber, Kirk ^d   Denysenko, Tetyana ^b   Bernabei, Paola ^b   Calisti, Gian Franco ^c   Papotti, Mauro ^e   Cappia, Susanna ^e   Pagni, Roberto ^f   Aimo, Giuseppe ^f   Mengozzi, Giulio ^f   Cavallo, Giovanni ^e   Reguzzi, Stefano ^a   Pescarmona, Gian Piero ^b,c   Ponzetto, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CERMS   (Italy)

^c Department of Genetics Biology and Biochemistry ^*  (Italy)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TURIN   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

Author keywords

Autologous transplantation; Liver; Liver cells; Liver stem cells; Stem cells

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; CYCLIN DEPENDENT KINASE 4; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 8; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 6; JAGGED1; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PROSTANOID; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

ALCOHOL LIVER DISEASE; CELL FUNCTION; CELL POPULATION; CELL RENEWAL; CELL STRUCTURE; CHOLESTASIS; CHRONIC LIVER DISEASE; COST BENEFIT ANALYSIS; HEPATITIS; HUMAN; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; LIVER REGENERATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PLASTICITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SELF EVALUATION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE ACTIVATION; VIRUS HEPATITIS;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER DISEASES; LIVER REGENERATION; OXIDATIVE STRESS; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 77953559697     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1630     Document Type: Review

References (112)

1. Stem Cells: Scientific Progress and Future Research Directions. Department of Health and Human Services website: http://stemcells.nih.gov/info/ scireport [21 June 2009].
2. Fausto N. Liver regeneration: from laboratory to clinic. Liver Transpl 2001; 7: 835-844.
3. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Development 1990; 110: 1001-1020.
4. Tateno C, Takai-Kajihara K, Yamasaki C, Sato H, Yoshizato K. Heterogeneity of growth potential of adult rat hepatocytes in vitro. Hepatology 2000; 31: 65-74.
5. Katayama S, Tateno C, Asahara T, Yoshizato K. Size-dependent in vivo growth potential of adult rat hepatocytes. Am J Pathol 2001; 158: 97-105.
6. Oh SH, Hatch HM, Petersen BE. Hepatic oval 'stem' cell in liver regeneration. Semin Cell Dev Biol 2002; 13(6): 405-409.
7. Petersen BE. Hepatic "stem" cells: coming full circle. Blood Cells Mol Dis 2001; 27(3): 590-600.
8. Menthena A, Deb N, Oertel M, et al. Bone marrow progenitors are not the source of expanding oval cells in injured liver. Stem Cells 2004; 22(6): 1049-1061.
9. Vig P, Russo FP, Edwards RJ, et al. The sources of parenchymal regeneration after chronic hepatocellular liver injury in mice. Hepatology 2006; 43(2): 316-324.
10. Gordon MY, Levicar N, Pai M, et al. Characterization and clinical application of human CD34=+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006; 24(7): 1822-1830.
11. Dan YY, Yeoh GC. Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 2008; 23(5): 687-698.
12. Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics- recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007; 82(3): 252-264.
13. Chandross KJ, Mezey E. Plasticity of Adult Bone Marrow Stem Cells, Mattson MP, Van Zant G (eds). JAI Press: Greenwich, CT, 2001.
14. Smith AG. Origins and properties of mouse embryonic stem cells. Annu Rev Cell Dev Biol 2001; 17: 435-462.
15. Slack JM. Stem cells in epithelial tissues. Science 2000; 287: 1431-1433.
16. Uzan G. Therapeutic use of stem cells. Rev Prat 2004; 54(13): 1399-1403.
17. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocytederived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003; 100(5): 2426-2431.
18. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000; 97(25): 13625-13630.
19. Ramadori G, Moriconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol 2008; 59(Suppl 1): 107-117.
20. Gebhardt R, Ebert A, Bauer G. Heterogeneous expression of glutamine synthetase mRNA in rat liver parenchyma revealed by in situ hybridization and Northern blot analysis of RNA from periportal and perivenous hepatocytes. FEBS Lett 1988; 241(1-2): 89-93.
21. Gumucio JJ. Hepatocyte heterogeneity: the coming of age from the description of a biological curiosity to a partial understanding of its physiological meaning and regulation. Hepatology 1989; 9(1): 154-160.
22. Traber P, Chianale J, Gumucio JJ. Physiologic significance and regulation of hepatocellular heterogeneity. Gastroenterology 1988; 95(4): 1130-1143.
23. Theise ND, Saxena R, Portmann BC, et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999; 30(6): 1425-1433.
24. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001; 161 (III-XIII): 1-151.
25. Malarkey DE, Johnson K, Ryan L, Boorman G, Maronpot RR. New insights into functional aspects of liver morphology. Toxicol Pathol 2005; 33(1): 27-34.
26. Desmouliere A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumour cell behavior. Int J Dev Biol 2004; 48(5-6): 509-517.
27. Fandrich F, Ruhnke M. Stem cells and liver replacement. Med Klin 2003; 98(2): 18-22.
28. Schaff Z, Nagy P. Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells. Orv Hetil 2004; 145(35): 1787-1793.
29. Tan J, Hytiroglou P, Wieczorek R, et al. Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver 2002; 22(5): 365-373.
30. Bioulac-Sage P, Blanc JF, Lepreux S, Balabaud C, Rosenbaum J, And Desmoulière A. Cirrhosis: forever? Gastroenterol Clin Biol 2000; 24: 877-882.
31. Nishio A, Keeffe EB, Gershwin ME. Primary biliary cirrhosis: lessons learned from an organ-specific disease. Clin Exp Med 2001; 1(4): 165-178.
32. Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci 2009; 14: 2923-2934.
33. Fausto N, Lemire JM, Shiojiri N. Cell lineages in hepatic development and the identification of progenitor cells in normal and injured liver. Proc Soc Exp Biol Med 1993; 204(3): 237-241.
34. Xu CS, Zhao LF, Yang KJ, Zhang JB. The origination and action of the hepatic stems cells. Shi Yan Sheng Wu Xue Bao 2004; 37(1): 72-77.
35. Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24(10): 2292-2298.
36. Sakaida I, Terai S, Okita K. Use of bone marrow cells for the development of cellular therapy in liver diseases. Hepatol Res 2005; 31(4): 195-196. (Pubitemid 40724075)
37. Vessey CJ, de la Hall PM. Hepatic stem cells: a review. Pathology 2001; 33(2): 130-141.
38. Zhang Y, Bai XF, Huang CX. Hepatic stem cells: existence and origin. World J Gastroenterol 2003; 9(2): 201-204.
39. Sancho-Bru P, Najimi M, Caruso M, et al. Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut 2009; 58(4): 594-603.
40. Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy. Semin Cell Dev Biol 2007; 18(6): 819-826.
41. Kountouras J, Boura P, Lygidakis NJ. Liver regeneration after hepatectomy. Hepatogastroenterology 2001; 48: 556-562.
42. Alison MR, Poulsom R, Forbes SJ. Update on hepatic stem cells. Liver 2001; 21: 367-373.
43. Alison M, Golding M, Lalani el-N, Sarraf C. Wound healing in the liver with particular reference to stem cells. Philos Trans R Soc Lond B Biol Sci 1998; 353(1370): 877-894.
44. Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997; 151: 1273-1280. (Pubitemid 27479757)
45. Kruglov EA, Jain D, Dranoff JA. Isolation of primary rat liver fibroblasts. J Investig Med 2002; 50: 179-184.
46. Lemire JM, Shiojiri N, Fausto N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol 1991; 139(3): 535-552.
47. Weber A, Mahieu-Caputo D, Hadchouel M, Franco D. Hepatocyte transplantation: studies in preclinical models. J Inherit Metab Dis 2006; 29(2-3): 436-441.
48. Crosby HA, Hubscher S, Fabris L, et al. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 1998; 152: 771-779.
49. Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic progenitor cells correlates with parenchymal inflammation in chronic viral hepatitis: can progenitor cells migrate. J Pathol 2000; 192: 373-378.
50. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 2001; 25: 1388-1396.
51. Lorenti AS. Hepatic stem cells. Medicina (B Aires) 2001; 61: 614-620.
52. Poliard AM, Bernuau D, Tournier I, et al. Cellular analysis by in situ hybridization and immunoperoxidase of alpha-fetoprotein and albumin gene expression in rat liver during the perinatal period. J Cell Biol 1986; 103: 777-786.
53. Kubota H, Storms RW, Reid LM. Variant forms of alpha-fetoprotein transcripts expressed in human hematopoietic progenitors: implications for their developmental potential toward endoderm. J Biol Chem 2002; 277: 27629-27635.
54. Mitsuhashi N, Kobayashi S, Doki T, et al. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. J Gastroenterol Hepatol 2008; 23(7 Pt 2): e189-e197.
55. Gordon GJ, Coleman WB, Hixson DC, Grisham JW. Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response. Am J Pathol 2000; 156: 607-619.
56. Yeoh GC, Ernst M, Rose-John S, et al. Opposing roles of gp130- mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation. Hepatology 2007; 45(2): 486-494.
57. Petersen BE. Hepatic Oval Cells: "Knocking on Forbidden Doors". Mary Ann Liebert, Inc.: New York, 2000; e-biomed Vol1.
58. Qin AL, Zhou XQ, Zhang W, Yu H, Xie Q. Characterization and enrichment of hepatic progenitor cells in adult rat liver. World J Gastroenterol 2004; 10(10): 1480-1486.
59. Erker L, Grompe M. Signaling networks in hepatic oval cell activation. Stem Cell Res 2007; 1(2): 90-102.
60. Gordon GJ, Coleman WB, Grisham JW. Temporal analysis of hepatocyte differentiation by small hepatocyte-like progenitor cells during liver regeneration in retrorsine-exposed rats. Am J Pathol 2000; 157: 771-786.
61. Rao MS, Reddy JK. Hepatic transdifferentiation in the pancreas. Semin Cell Biol 1995; 6(3): 151-156.
62. Bartles JR, Zhang L, Fayos BE, Nehem CL, Reddy JK. Expression and compartmentalization of integral plasma membrane proteins by hepatocytes and their progenitors in the rat pancreas. J Cell Sci 1991; 98(1): 45-54.
63. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001; 15(8): 1335-1349.
64. Shiojiri N, Lemire JM, Fausto N. Cancer Res 1991; 51(10): 2611-2620.
65. Farber E. Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Digest Dis Sci 1991; 36(7): 973-978.
66. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120(1): 117-130.
67. de Lima VM, Oliveira CP, Alves VA, et al. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol 2008; 49(6): 1055-1061.
68. Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163(4): 1301-1311.
69. Ohlson LC, Koroxenidou L, Hallstrom IP. Inhibition of in vivo rat liver regeneration by 2-acetylaminofluorene affects the regulation of cell cycle-related proteins. Hepatology 1998; 27(3): 691-696.
70. Lindeman B, Skarpen E, Oksvold MP, Huitfeldt HS. The carcinogen 2-acetylaminofluorene inhibits activation and nuclear accumulation of cyclin-dependent kinase 2 in growth-induced rat liver. Mol Carcinog 2000; 27(3): 190-199.
71. Jung J, Zheng M, Goldfarb M, Zaret KS. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 1999; 284: 1998-2003.
72. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001; 15(8): 1335-1349.
73. Crary GS, Albrecht JH. Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 1998; 28(3): 738-743.
74. Wands JR, Carter EA, Bucher NL, Isselbacher KJ. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology 1979; 77(3): 528-531.
75. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002; 60(9): 289-293.
76. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000; 31(1): 35-42.
77. Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 2001; 34(4 Pt 1): 694-706.
78. Thorgeirsson SS, Factor VM, Snyderwine EG. Transgenic mouse models in carcinogenesis research and testing. Toxicol Lett 2000; 112-113: 553-555.
79. Evarts RP, Nagy P, Marsden E, Thorgeirsson SS. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987; 8(11): 1737-1740.
80. Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989; 134(6): 1347-1363.
81. Libbrecht L, Meerman L, Kuipers F, Roskams T, Desmet V, Jansen P. Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria. J Pathol 2003; 199(2): 191-200.
82. Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thorgeirsson SS. Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 1992; 16(6): 1327-1333.
83. Yang S, Koteish A, Lin H, et al. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. Hepatology 2004; 39(2): 403-411.
84. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213(2): 286-300.
85. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43(2 Suppl 1): S45-S53.
86. Zhang W, Chen XP, Zhang WG, et al. Hepatic non-parenchymal cells and extracellular matrix participate in oval cell-mediated liver regeneration. World J Gastroenterol 2009; 15(5): 552-560.
87. Itoh T, Kamiya Y, Okabe M, Tanaka M, Miyajima A. Inducible expression of Wnt genes during adult hepatic stem/progenitor cell response. FEBS Lett 2009; 583(4): 777-781.
88. Rossi JM, Dunn NR, Hogan BL, Zaret KS. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 2001; 15: 1998-2009.
89. Reya T, Morrison SJ, ClarkeMF,Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
90. Sekhon SS, Tan X, Micsenyi A, Bowen WC, Monga SPS. Fibroblast growth factor enriches the embryonic liver cultures for hepatic progenitors. Am J Pathol 2004; 164: 2229-2240.
91. Mimeault M, Batra SK. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 2006; 24(11): 2319-2345.
92. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001; 105: 425-431.
93. Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol 1999; 155: 703-710.
94. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001; 33: 1098-1109.
95. Hussain SZ, Sneddon T, Tan X, Micsenyi A, Michalopoulos GK, Monga SP. Wnt impacts growth and differentiation in ex vivo liver development. Exp Cell Res 2004; 292: 157-169.
96. Monga SP, Monga HK, Tan X, Mule K, Pediaditakis P, Michalopoulos GK. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 2003; 124: 202-216.
97. Monga SP, Tang Y, Candotti F, et al. Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explants. Cell Transplant 2001; 10: 81-89.
98. Amin R, Mishra L. Liver stem cells and tgf-beta in hepatic carcinogenesis. Gastrointest Cancer Res 2008; 2(4 Suppl): S27-S30.
99. MishraL,Cai T, Yu P, Monga SP, Mishra B. Elf3 encodes a novel 200-kD beta-spectrin: role in liver development. Oncogene 1999; 18: 353-364.
100. Mishra L, Tully RE, Monga SP, et al. Praja1, a novel gene encoding a RING-H2 motif in mouse development. Oncogene 1997; 15: 2361-2368.
101. Su TT. The regulation of cell growth and proliferation during organogenesis. In Vivo 2000; 14: 141-148.
102. Ber T, Rountree CB, Lee L, et al. Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology 2007; 46(4): 1187-1197.
103. Foster JR. Cell death and cell proliferation in the control of normal and neoplastic tissue growth. Toxicol Pathol 2000; 28: 441-446.
104. Gerlach JC, Zeilinger K, Sauer IM, et al. Extracorporeal liver support: porcine or human cell based systems? Int J Artif Organs 2002; 25: 1013-1018.
105. Patzer JF, II. Advances in bioartificial liver assist devices. Ann NY Acad Sci 2001; 944: 320-333.
106. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999; 19: 39-48.
107. Jung YJ, Ryu KH, Cho KA, et al. In vitro hepatic differentiation of human umbilical cord blood and bone marrow cells. Pediatr Hematol Oncol 2008; 25(6): 481-491.
108. Piscaglia AC, Novi M, Campanale M, Gasbarrini A. Stem cell-based therapy in gastroenterology and hepatology. Minim Invasive Ther Allied Technol 2008; 17(2): 100-118.
109. Bae SH. Clinical application of stem cells in liver diseases. Korean J Hepatol 2008; 14(3): 309-317.
110. Haridass D, Narain N, Ott M. Hepatocyte transplantation: waiting for stem cells. Curr Opin Organ Transplant 2008; 13(6): 627-632.
111. Takubo K, Nakamura K, Izumiyama N, et al. Telomere shortening with aging in human liver. J Gerontol A Biol Sci Med Sci 2000; 55(11): B533-B536.
112. Kokubun E, Hirabara SM, Fiamoncini J, Curi R, Haebisch H. Changes of glycogen content in liver, skeletal muscle, and heart from fasted rats. Cell Biochem Funct 2009; 27(7): 488-495.